Search results
Jump to navigation
Jump to search
- The chemical reactions and pathways resulting in the formation of cannabinoid.3 statements, 0 sitelinks - 20:49, 7 March 2023
- The series of molecular signals generated as a consequence of a cannabinoid binding to a cell surface receptor. The pathway proceeds with the receptor transmitting the signal to a heterotrimeric G-protein complex and ends with regulation of a downstr3 statements, 0 sitelinks - 20:47, 7 March 2023
- Combining with a cannabinoid to initiate a change in cell activity. Cannabinoids are a class of diverse chemical compounds that include the endocannabinoids and the phytocannabinoids.4 statements, 0 sitelinks - 20:47, 7 March 2023
- class of chemical compounds6 statements, 0 sitelinks - 20:50, 7 March 2023
- * [[Cannabinoid receptor antagonist/ja|カンナビノイド受容体拮抗薬]]が肥満治療のために開発されたのは、カンナビノイド作動薬（[[cannabi |[[Cannabinoid receptor antagonist/ja]] ...22 KB (659 words) - 09:48, 8 March 2024
- ...gonist]]s were developed to treat obesity because researchers noticed that cannabinoid agonists (such as [[THC]], the main pharmacologically active component of [ |[[Cannabinoid receptor antagonist]] ...17 KB (2,406 words) - 18:16, 7 March 2024
- ...gonist]]s were developed to treat obesity because researchers noticed that cannabinoid agonists (such as [[THC]], the main pharmacologically active component of [ |[[Cannabinoid receptor antagonist]] ...18 KB (2,460 words) - 18:15, 7 March 2024
- ...ル[[Acyl carrier protein/ja|ACP]]誘導体、脂肪酸カルニチンなどの重要な生化学的中間体が含まれる。脂肪アミドとしては、[[cannabinoid/ja|カンナビノイド]]神経伝達物質[[anandamide/ja|アナンダミド]]などの[[N-acylethanolamine/ja|N-アシルエ ...42 KB (1,589 words) - 10:44, 25 February 2024
- ...ption/ja|抗侵害受容性]]、[[anxiolytic/ja|抗不安性]]、[[Nervous system/ja|神経原性]]の特性を持つ[[Cannabinoid/ja#Endocannabinoids|エンドカンナビノイド]]の[[Biosynthesis/ja|生合成]]前駆体である。 ...43 KB (2,252 words) - 09:46, 27 February 2024
- ...[[cholinergic/ja|コリン作動薬]]、[[anticholinergic/ja|抗コリン薬]]、[[emetic/ja|催吐薬]]、[[cannabinoid/ja|カンナビノイド]]、[[serotonin antagonist/ja|5-HT（セロトニン）拮抗薬]]などがある。 ...58 KB (1,845 words) - 17:09, 5 November 2023
- ...s, [[anticholinergic|anticholinergic]]s, [[emetic|emetic]]s, [[cannabinoid|cannabinoid]]s, and [[serotonin antagonist|5-HT (serotonin) antagonists]]. ...52 KB (6,923 words) - 17:09, 5 November 2023
- ...]], [[glutamate]], [[GABA]], [[dopamine]], [[histamine]], [[serotonin]], [[cannabinoid]] and [[opioid]]. ...30 KB (3,998 words) - 20:36, 8 January 2023
- [[Synthetic cannabinoid]]s have been produced for a longer period of time and are used in the desig ...31 KB (4,168 words) - 09:37, 7 January 2023
- ...s, [[anticholinergic|anticholinergic]]s, [[emetic|emetic]]s, [[cannabinoid|cannabinoid]]s, and [[serotonin antagonist|5-HT (serotonin) antagonists]]. ...54 KB (7,245 words) - 17:08, 5 November 2023
- ...id|omega-6]] fatty acids are [[Biosynthesis|biosynthetic]] precursors to [[Cannabinoid#Endocannabinoids|endocannabinoids]] with [[Nociception|antinociceptive]], [ ...37 KB (5,301 words) - 12:29, 26 February 2024
- ...id|omega-6]] fatty acids are [[Biosynthesis|biosynthetic]] precursors to [[Cannabinoid#Endocannabinoids|endocannabinoids]] with [[Nociception|antinociceptive]], [ ...38 KB (5,433 words) - 12:26, 26 February 2024
- ...amides include [[N-acylethanolamine|N-acyl ethanolamines]], such as the [[cannabinoid]] neurotransmitter [[anandamide]]. ...33 KB (4,609 words) - 23:09, 24 February 2024
- ...amides include [[N-acylethanolamine|N-acyl ethanolamines]], such as the [[cannabinoid]] neurotransmitter [[anandamide]]. ...34 KB (4,723 words) - 23:09, 24 February 2024
- ...]], [[glutamate]], [[GABA]], [[dopamine]], [[histamine]], [[serotonin]], [[cannabinoid]] and [[opioid]]. ...46 KB (5,967 words) - 12:23, 15 November 2023